Predictive Biomarker Validation

Predictive Biomarker Validation is the systematic assessment of a biomarker's ability to accurately forecast the future occurrence or risk of a specific clinical outcome, such as gestational diabetes, through rigorous statistical, experimental, and translational evaluation in well-defined populations.

210

Publications

11.1K

Citations

2.2K

Authors

839

Institutions

Publications per year

2017–2026

127

Authors

2.2K

  1. SJ
    Sumithra J. Mandrekar

    Mayo Clinic, United States

    3 publications · 522 citations

    3

    h-index

  2. OP
    Oluf Pedersen

    University of Copenhagen, Denmark

    3 publications · 179 citations

    3

    h-index

  3. DM
    Dipen M. Maru

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 234 citations

    3

    h-index

  4. TH
    Torben Hansen

    University of Copenhagen, Denmark

    3 publications · 179 citations

    3

    h-index

  5. PL
    Pierre Laurent‐Puig

    Inserm, France

    3 publications · 95 citations

    3

    h-index

1–5 of 2.2K

Venues

  1. Journal of Clinical Oncology

    9 publications · 773 citations

    9

    h-index

  2. Cancers

    8 publications · 186 citations

    8

    h-index

  3. Clinical Cancer Research

    7 publications · 319 citations

    7

    h-index

  4. PubMed

    Repository · 6 publications · 103 citations

    6

    h-index

  5. Scientific Reports

    4 publications · 242 citations

    4

    h-index

1–5